Other side effects can include headaches, fatigue, dehydration, and dizziness
Cch s dng: Ung 1 vin mi ngy, trc hoc sau ba n, trong 3 thng
Thus, incubating human and rodent islets under high glucose conditions results in increased expression of PC1/3 and increased secretion of GLP-1 (101, 108110), while exposure of -cells to the proinflammatory cytokine, interleukin-6, also increased GLP-1 secretion (112)
Discontinuing prescribed therapy may lead to a rebound in body weight
While the exclusion of weight management treatment may limit reimbursement of GLP-1s, non-obesity/overweight diseases such as diabetes mellitus and certain cardiovascular conditions may be eligible for reimbursement because these indications are not excluded
Research terminology only